IPO Issue Details
Issue Price / Price Band₹1,258 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size11 Shares per Lot
Total Issue Size1,27,20,044 shares (aggregating up to ₹1,600.00 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenFri, 09 Feb 2024
Subscription CloseTue, 13 Feb 2024
Anchor AllotmentThu, 08 Feb 2024
Basis of AllotmentWed, 14 Feb 2024
Initiation of RefundsThu, 15 Feb 2024
Credit of Shares to DematThu, 15 Feb 2024
Listing DateFri, 16 Feb 2024
UPI Mandate Deadline2024-02-13
Application & Investment Details
Retail — Min (1 Lots)₹13,838 — 11 shares
Retail — Max (13 Lots)₹179,894 (13 Lots)
HNI — Min (73 Lots)₹10,10,174 — 803 shares
EPS (Pre-IPO)₹0.00
EPS (Post-IPO)₹9.70
P/E Ratio (Post-IPO)129.75x
Pre-IPO Promoter Holding3,95,77,705 shares
Post-IPO Promoter Holding4,75,26,830 shares
Fresh Issue Shares79,52,518 shares (aggregating up to ₹1,000.31 Cr)
Offer for Sale Shares47,67,526 shares of ₹10 (aggregating up to ₹599.69 Cr)
About Entero Healthcare Solutions Ltd.
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.During the fiscal years 2021, 2022, and 2023, the company served over 39,500, 64,200, and 81,400 retail customers, respectively. Additionally, they also served over 1,600, 2,500, and 3,400 hospital customers during the same period.Entero Healthcare Solutions has relationships with over 1,900 healthcare product manufacturers, giving them access to over 64,500 product stock-keeping units as of March 31, 2023.The company has 73 warehouses in 37 cities across 19 states and union territories, and its customer base includes over 81,400 pharmacies and 3,400 hospitals in 495 districts as of March 31, 2023. This provides excellent access to healthcare product manufacturers.As of 31st March, 2023, the company employs a total of 3014 people in various departments.
Objects of the Issue
Entero Healthcare Solutions Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
Repayment/prepayment, in full or part, of certain borrowings availed of by the company and its Subsidiaries.
2
Funding the long term working capital requirements.
3
Pursuing inorganic growth initiatives through acquisitions.
4
General corporate purposes.
Shareholding & Lock-in
Pre-IPO Promoter Holding
3,95,77,705 shares
Post-IPO Promoter Holding
4,75,26,830 shares
Lock-in Period (30%)March 15, 2024
Lock-in Period (50%)May 14, 2024